• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Xenia Hotels & Resorts Announces the Appointment of Terrence Moorehead to its Board of Directors

    5/26/21 6:30:00 AM ET
    $XHR
    $NATR
    Hotels/Resorts
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $XHR alert in real time by email

    ORLANDO, Fla., May 26, 2021 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. (NYSE:XHR) ("Xenia" or the "Company") today announced the appointment of Mr. Terrence Moorehead to its Board of Directors, effective May 25, 2021.  Mr. Moorehead was also appointed as a member of the Audit Committee effective May 25, 2021. With the appointment, the Company's Board of Directors increased to nine members, eight of whom are independent, including Mr. Moorehead. 

    "On behalf of the Board of Directors and the management team, we are pleased to welcome Terrence to our Board," commented Marcel Verbaas, Chairman and Chief Executive Officer of Xenia.  "Terrence brings a fresh and diverse perspective to the Board, and we look forward to his contributions that will further enhance our leadership. His expertise in high-end consumer products and behaviors as well as his experience in and focus on health and wellness are valuable attributes that are directly relevant to the upper upscale and luxury lodging segments. Additionally, his strategic insights that have been honed by executive leadership roles throughout the world will be of significant value."

    Mr. Moorehead currently serves as President, Chief Executive Officer, and a director on the board of Nature's Sunshine Products, Inc (NASDAQ:NATR) ("Nature's Sunshine"), a leading natural health and wellness company.  Prior to joining Nature's Sunshine in 2018, Mr. Moorehead was Chief Executive Officer at Carlisle Etcetera LLC from 2015 through 2018, and at Dana Beauty, Inc. from 2013 to 2015.  From 1991 to 2013 he served in various capacities at Avon Products, Inc., including, among other positions, as VP, Strategy and Digital, North America, President and Chairman of Avon Japan, President of Avon Canada, and General Manager of Avon Italy. 

    Mr. Moorehead received his Master of Business Administration from Columbia University and a Bachelor of Arts in Economics from Boston College.

    "I am excited to be joining Xenia's Board of Directors and to have the opportunity to work with such an outstanding team of professionals. The Company's high-quality properties, differentiated portfolio, and top-notch management team are a powerful combination and I look forward to working with the team to deliver increased shareholder value," commented Mr. Moorehead.

    About Xenia Hotels & Resorts, Inc.

    Xenia Hotels & Resorts, Inc. is a self-advised and self-administered REIT that invests in uniquely positioned luxury and upper upscale hotels and resorts with a focus on the top 25 U.S. lodging markets as well as key leisure destinations in the United States. The Company owns 35 hotels and resorts comprising 10,011 rooms across 15 states. Xenia's hotels are in the luxury and upper upscale segments, and are operated and/or licensed by industry leaders such as Marriott, Hyatt, Kimpton, Fairmont, Loews, Hilton, and The Kessler Collection. For more information on Xenia's business, refer to the Company website at www.xeniareit.com.

    This press release contains statements as to the Company's beliefs and expectations of the outcome of future events that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. You can identify these statements by the fact that they do not relate strictly to historical or current facts. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made. These risks and uncertainties include, but are not limited to, the effects of the COVID-19 pandemic, including on the demand for travel, transient and group business (including, but not limited to, government-imposed travel or meeting restrictions), and levels of consumer confidence in the safety of travel as a result of the pandemic; the length of the COVID-19 pandemic and severity of such pandemic in the United States; the pace of economic recovery and the recovering of consumer confidence following the COVID-19 pandemic; our ability to implement cost-containment strategies; the adverse effects of the COVID-19 pandemic on our business or the market price of our common stock; and our ability to service, restructure or refinance our debt; our ability to be in compliance with our debt covenants; our ability to access capital on acceptable terms or at all and uncertainty in both the debt and equity capital markets; and the outcome of legal proceedings or other disputes. Other factors that could cause results to differ are described in the filings made from time to time by the Company with the U.S. Securities and Exchange Commission and include the risk factors and other risks and uncertainties described in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 and its Current Reports on Form 8-K. Except as required by law, the Company does not undertake, and hereby disclaims, any obligation to release publicly any revisions to forward-looking statements made by it to reflect events or circumstances occurring after the date hereof or the occurrence of unanticipated events.

    Cision View original content:http://www.prnewswire.com/news-releases/xenia-hotels--resorts-announces-the-appointment-of-terrence-moorehead-to-its-board-of-directors-301299385.html

    SOURCE Xenia Hotels & Resorts, Inc.

    Get the next $XHR alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $XHR
    $NATR

    CompanyDatePrice TargetRatingAnalyst
    Nature's Sunshine Products Inc.
    $NATR
    5/7/2025$19.00Buy
    DA Davidson
    Xenia Hotels & Resorts Inc.
    $XHR
    4/9/2025$10.00Buy → Hold
    Jefferies
    Xenia Hotels & Resorts Inc.
    $XHR
    9/13/2024$16.00 → $15.00Equal Weight → Overweight
    Wells Fargo
    Nature's Sunshine Products Inc.
    $NATR
    9/13/2024$18.00Buy
    Canaccord Genuity
    Xenia Hotels & Resorts Inc.
    $XHR
    3/4/2024$16.00 → $17.00Buy → Neutral
    B. Riley Securities
    Xenia Hotels & Resorts Inc.
    $XHR
    2/29/2024$14.00 → $18.00Hold → Buy
    Jefferies
    Xenia Hotels & Resorts Inc.
    $XHR
    1/10/2024Peer Perform
    Wolfe Research
    Xenia Hotels & Resorts Inc.
    $XHR
    3/30/2023$18.00 → $13.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $XHR
    $NATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Shanghai Fosun Pharmaceutical (Group) Co., Ltd. sold $32,713,796 worth of shares (2,854,607 units at $11.46) (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      6/27/25 4:27:23 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • New insider Fosun Pharma Usa Inc. claimed ownership of 2,854,607 shares (SEC Form 3)

      3 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      6/9/25 4:32:08 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Goulet, Beverly K.

      4 - Xenia Hotels & Resorts, Inc. (0001616000) (Issuer)

      5/14/25 4:34:21 PM ET
      $XHR
      Hotels/Resorts
      Consumer Discretionary

    $XHR
    $NATR
    SEC Filings

    See more
    • SEC Form 8-K filed by Nature's Sunshine Products Inc.

      8-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      6/27/25 8:31:04 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 424B5 filed by Nature's Sunshine Products Inc.

      424B5 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      6/27/25 7:23:14 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 424B5 filed by Nature's Sunshine Products Inc.

      424B5 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      6/25/25 4:01:22 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $XHR
    $NATR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Nature's Sunshine Products, Inc. Announces Pricing of Secondary Public Offering of Common Stock

      LEHI, Utah, June 26, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" or the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the pricing of an underwritten secondary public offering of up to 2,854,607 shares of its common stock to be sold by Fosun Pharma USA, Inc (the "Selling Stockholder"). The shares of common stock are being sold at a price of $12.00 per share. The offering is expected to close on June 27, 2025, subject to customary closing conditions. The Selling Stockholder will receive all of the net proceeds from the offering. Nature's Sunshine is not selling any shares of common stoc

      6/26/25 6:30:00 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Products, Inc. Announces Launch of Secondary Public Offering of Common Stock

      LEHI, Utah, June 25, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" or the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the launch of an underwritten secondary public offering of up to 2,854,607 shares of its common stock to be sold by Fosun Pharma USA, Inc (the "Selling Stockholder"). The Selling Stockholder will receive all of the net proceeds from the offering. Nature's Sunshine is not selling any shares of common stock in the offering and will not receive any proceeds from the offering. The Selling Stockholder will pay any underwriting discounts and commissions and transfer taxes at

      6/25/25 4:01:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Xenia Hotels & Resorts Announces Timing of Second Quarter 2025 Earnings Release and Conference Call

      ORLANDO, Fla., June 13, 2025 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. (NYSE:XHR) ("Xenia" or the "Company") will report financial results for the second quarter 2025 before the market opens on Friday, August 1, 2025. Management will discuss the Company's results during a conference call at 10:00 am (Eastern Time) that day. To participate in the conference call, please follow the steps listed below: Friday, August 1, 2025, dial (833) 470-1428 approximately ten minutes before the call begins, access code 728188. Tell the operator that you are calling for Xenia Hotels & Resorts' Second Quarter 2025 Earnings Conference Call. State your full name and company affiliation and you will be connec

      6/13/25 6:30:00 AM ET
      $XHR
      Hotels/Resorts
      Consumer Discretionary

    $XHR
    $NATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • DA Davidson resumed coverage on Nature's Sunshine with a new price target

      DA Davidson resumed coverage of Nature's Sunshine with a rating of Buy and set a new price target of $19.00

      5/7/25 8:37:48 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Xenia Hotels downgraded by Jefferies with a new price target

      Jefferies downgraded Xenia Hotels from Buy to Hold and set a new price target of $10.00

      4/9/25 8:06:14 AM ET
      $XHR
      Hotels/Resorts
      Consumer Discretionary
    • Xenia Hotels upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded Xenia Hotels from Equal Weight to Overweight and set a new price target of $15.00 from $16.00 previously

      9/13/24 7:48:19 AM ET
      $XHR
      Hotels/Resorts
      Consumer Discretionary

    $XHR
    $NATR
    Financials

    Live finance-specific insights

    See more
    • Xenia Hotels & Resorts Announces Timing of Second Quarter 2025 Earnings Release and Conference Call

      ORLANDO, Fla., June 13, 2025 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. (NYSE:XHR) ("Xenia" or the "Company") will report financial results for the second quarter 2025 before the market opens on Friday, August 1, 2025. Management will discuss the Company's results during a conference call at 10:00 am (Eastern Time) that day. To participate in the conference call, please follow the steps listed below: Friday, August 1, 2025, dial (833) 470-1428 approximately ten minutes before the call begins, access code 728188. Tell the operator that you are calling for Xenia Hotels & Resorts' Second Quarter 2025 Earnings Conference Call. State your full name and company affiliation and you will be connec

      6/13/25 6:30:00 AM ET
      $XHR
      Hotels/Resorts
      Consumer Discretionary
    • Xenia Hotels & Resorts Declares Dividend for Second Quarter 2025 and Announces Board Approval for a $100 Million Increase in Share Repurchase Program

      ORLANDO, Fla., May 14, 2025 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. (NYSE:XHR) ("Xenia" or the "Company") today announced that its Board of Directors authorized a cash dividend of $0.14 per share of the Company's common stock for the second quarter 2025. The dividend will be paid on July 15, 2025, to all holders of record of the Company's common stock as of the close of business on June 30, 2025. In addition, the Company's Board of Directors authorized the repurchase of up to an additional $100 million of the Company's outstanding common shares. Repurchases may be made in the open market and privately negotiated transactions, or by other means, including Rule 10b5-1 trading plans. The r

      5/14/25 6:30:00 AM ET
      $XHR
      Hotels/Resorts
      Consumer Discretionary
    • Nature's Sunshine Reports Strong First Quarter 2025 Results

      LEHI, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 2% to $113.2 million compared to $111.0 million (up 5% in constant currency).GAAP net income attributable to common shareholders was up 104% to $4.7 million, or $0.25 per diluted common share, compared to $2.3 million, or $0.12 per diluted common share.Adjusted EBITDA was up 20% to $11.0 million compared to $9.2 million. Capital Allocation Na

      5/6/25 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $XHR
    $NATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Xenia Hotels & Resorts Inc. (Amendment)

      SC 13G/A - Xenia Hotels & Resorts, Inc. (0001616000) (Subject)

      2/13/24 5:17:34 PM ET
      $XHR
      Hotels/Resorts
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

      SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

      2/12/24 10:37:49 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed by Xenia Hotels & Resorts Inc. (Amendment)

      SC 13G/A - Xenia Hotels & Resorts, Inc. (0001616000) (Subject)

      2/9/24 8:40:49 AM ET
      $XHR
      Hotels/Resorts
      Consumer Discretionary

    $XHR
    $NATR
    Leadership Updates

    Live Leadership Updates

    See more
    • Nature's Sunshine Announces Leadership Transition Plan

      Board Initiates CEO Search Process Terrence Moorehead to Step Down as President and CEO, Once Successor Appointed Company Reaffirms Full Year 2025 Outlook LEHI, Utah, June 02, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that Terrence Moorehead has notified the Company's Board of Directors (the "Board") of his decision to step down as President and Chief Executive Officer, effective upon the appointment of a successor. At that time, Mr. Moorehead will also resign as a member of the Board of Directors. The Nature's Sunshine Board ha

      6/2/25 9:00:00 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Appoints Heidi Wissmiller as Chairman of the Board

      LEHI, Utah, May 05, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading natural health and wellness company of high-quality herbal and nutritional products, today announced the appointment of Heidi Wissmiller as Chairman of the Board of Directors, effective April 30, 2025. She succeeds Richard D. Moss, who has retired after serving as a Director since 2018 and Chairman since 2022. Ms. Wissmiller has served on the Board of Nature's Sunshine since 2020. Over the course of her tenure, she has chaired the Governance and Risk Management Committees. As Chief Growth Officer at Rodan + Fields ("R+F"), the leading skincare brand in North America, Ms. Wissmiller led

      5/5/25 8:00:00 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Appoints Katie A. May to Board of Directors

      LEHI, Utah, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Ms. Katie A. May to its board of directors effective January 30, 2025. Nature's Sunshine's board will now consist of ten directors with nine serving as independent directors. "Katie brings significant experience scaling and leading high-growth B2C, ecommerce and logistics companies," said Richard D. Moss, Chairman of the Board of Nature's Sunshine. "Her deep understanding of the full ecommerce lifecycle will strengthen and enhance our digital capabilities and drive s

      2/5/25 4:05:00 PM ET
      $NATR
      $PBI
      $STMP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Office Equipment/Supplies/Services
      Miscellaneous